Glucotrack Reports Unregistered Equity Sale
Ticker: GCTK · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities, capital-raise
TL;DR
Glucotrack sold unregistered equity, details TBD.
AI Summary
Glucotrack, Inc. reported on January 6, 2025, an unregistered sale of equity securities. The filing does not disclose the specific number of shares sold or the aggregate purchase price, but it indicates a transaction occurred under the Securities Act of 1933.
Why It Matters
This filing indicates a potential dilution of existing shares or a capital raise, which could impact the stock price and ownership structure.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes signal financial distress or a need for capital, and the lack of specific details in this initial report warrants caution.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Securities Act of 1933 (legal_document) — Governing regulation for the sale
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities.
What was the date of the earliest event reported?
The date of the earliest event reported is January 6, 2025.
What is Glucotrack, Inc.'s principal executive office address?
The address is 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number is 98-0668934.
Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 13.4 · Accepted 2025-01-13 17:29:09
Key Financial Figures
- $0.001 — s") to purchase common stock, par value $0.001 per share of the Company. Beginning o
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-25-001982.txt ( ) — 210KB
- gctk-20250106.xsd (EX-101.SCH) — 3KB
- gctk-20250106_lab.xml (EX-101.LAB) — 33KB
- gctk-20250106_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer